Last week, AAHKS submitted our comments to the Centers for Medicare and Medicaid Services (CMS) on their CY2022 Medicare Inpatient Prospective Payment System Proposed Rule. Our comments included support for adjusting Hospital-Level 30-Day, All-Cause Risk-Standardized Readmission Rate (RSRR) following elective primary THA/TKA to exclude COVID-19 diagnosed patients from the measure denominators; support for adding the “Patient-Reported Outcome-Based Performance Measure Hospital-Level, Risk-Standardized Improvement Rate in Patient-Reported Outcomes Following Elective Primary Total Hip and/or Total Knee Arthroplasty” (NQF ID # 3559) to the Hospital Inpatient Quality Reporting (IQR) Program; and repeal of the collection and disclosure of providers’ payer-specific negotiated rates. For details, read our letter. You can also review the AAOS’s comment letter, which we  co-signed.

Close Bitnami banner